281 related articles for article (PubMed ID: 9665228)
1. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).
Herrington DM; Fong J; Sempos CT; Black DM; Schrott HG; Rautaharju P; Bachorik PS; Blumenthal R; Khan S; Wenger NK
Am Heart J; 1998 Jul; 136(1):115-24. PubMed ID: 9665228
[TBL] [Abstract][Full Text] [Related]
2. Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics.
Grady D; Applegate W; Bush T; Furberg C; Riggs B; Hulley SB
Control Clin Trials; 1998 Aug; 19(4):314-35. PubMed ID: 9683309
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N;
JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
[TBL] [Abstract][Full Text] [Related]
5. The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS).
Simon JA; Lin F; Vittinghoff E; Bittner V;
Ann Epidemiol; 2006 Feb; 16(2):138-45. PubMed ID: 16039873
[TBL] [Abstract][Full Text] [Related]
6. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
[TBL] [Abstract][Full Text] [Related]
7. Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?
Shlipak MG; Stehman-Breen C; Vittinghoff E; Lin F; Varosy PD; Wenger NK; Furberg CD;
Am J Kidney Dis; 2004 Jan; 43(1):37-44. PubMed ID: 14712425
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
Contreras I; Parra D
Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
[TBL] [Abstract][Full Text] [Related]
9. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study.
Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH
Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152
[TBL] [Abstract][Full Text] [Related]
10. Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS).
Shlipak MG; Chaput LA; Vittinghoff E; Lin F; Bittner V; Knopp RH; Hulley SB;
Am Heart J; 2003 Nov; 146(5):870-5. PubMed ID: 14597937
[TBL] [Abstract][Full Text] [Related]
11. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women.
Dallongeville J; Marecaux N; Isorez D; Zylbergberg G; Fruchart JC; Amouyel P
Atherosclerosis; 1995 Nov; 118(1):123-33. PubMed ID: 8579622
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.
Rosano GM; Fini M
Cardiol Rev; 2002; 10(1):51-60. PubMed ID: 11790270
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS).
Simon JA; Hsia J; Cauley JA; Richards C; Harris F; Fong J; Barrett-Connor E; Hulley SB
Circulation; 2001 Feb; 103(5):638-42. PubMed ID: 11156873
[TBL] [Abstract][Full Text] [Related]
14. Hormones and heart disease in women: Heart and Estrogen/Progestin Replacement Study in perspective.
Barrett-Connor E; Stuenkel C
J Clin Endocrinol Metab; 1999 Jun; 84(6):1848-53. PubMed ID: 10372673
[TBL] [Abstract][Full Text] [Related]
15. Comparative cardiovascular effects of different progestins in menopause.
Rosano GM; Fini M
Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
[TBL] [Abstract][Full Text] [Related]
16. The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study.
Herrington DM
Ann Intern Med; 1999 Sep; 131(6):463-6. PubMed ID: 10498564
[TBL] [Abstract][Full Text] [Related]
17. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate.
Hulley S
Can J Cardiol; 2000 Aug; 16 Suppl E():10E-12E. PubMed ID: 10906618
[TBL] [Abstract][Full Text] [Related]
18. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
19. Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.
Nair GV; Chaput LA; Vittinghoff E; Herrington DM;
Chest; 2005 May; 127(5):1498-506. PubMed ID: 15888820
[TBL] [Abstract][Full Text] [Related]
20. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
Mohandas B; Mehta JL
Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
